starboard tylenol news

Activist Starboard Holds Kenvue Stake, Seeks Changes

Starboard reportedly takes big stake in Tylenol maker Kenvue

Activist investor Starboard Value has taken a sizeable stake in Kenvue, the maker of Tylenol and Listerine, and is seeking changes, according to reports Sunday night.

BioSpace · 19h

Activist Investor Starboard Takes Aim at J&J Spinoff Kenvue on Heels of $1B Stake in Pfizer

Starboard Value contends that Kenvue, with strong consumer health brands like Tylenol and Listerine, is underperforming its rivals, according to The Wall Street Journal.

Seeking Alpha · 2d

Activist investor Starboard takes stake in Kenvue - WSJ

Financial writer reports activist investor Starboard Value's stake in Kenvue Inc., seeking measures to boost stock price.

Kenvue, Starboard Value

Reuters · 16h

Starboard says Kenvue's skin health segment weighing on performance

Starboard Value called consumer products company Kenvue a bargain and said its skin health and beauty segment's lackluster growth is the reason for the stock's underperformance.

Barron's on MSN · 1d

Starboard Targets Another Health Company. Why Kenvue Is in Its Sights.

Tylenol, Listerine and Band-Aid maker Kenvue is the latest in the health related sector to attract an activist investor. And not just any corporate agitator, Starboard Value, which in recent days targeted pharma giant Pfizer.

Seeking Alpha on MSN · 12h

Kenvue needs to fix its skin, health & beauty segments, Starboard's Jeff Smith says (update)

Adds Kenvue comment. Kenvue (NYSE:KVUE) needs to focus on fixing its skin, health and beauty segments, Jeff Smith, founder and CEO of activist hedge fund Starboard Value said. "We are having conversations with them and there are signs that Kenvue is already going in the right direction,

2don MSN

Activist Starboard Value Takes Stake in Tylenol-Maker Kenvue

Starboard wants Kenvue, which was spun out of Johnson & Johnson last year and has a market value of over $40 billion, to make ...

Yahoo Finance1d

Kenvue stock jumps on reports of Starboard Value's stake

The Wall Street Journal reported Starboard taking a "sizable stake" in the Tylenol and Band-Aids maker and hopes to boost ...

17h

Starboard calls for Pfizer board to ‘hold management accountable’

Jeff Smith says pharma giant’s returns from recent efforts are ‘not adequate’ in speech at 13D activist investor conference ...

Starboard Focused on Kenvue's Struggling Unit

Starboard Chief Executive Jeff Smith said that Kenvue, the Tylenol-maker spun out from Johnson & Johnson, should drill down on fixing its underperforming skin health and beauty segment, which he ...

FiercePharma1d

Activist investor Starboard sets its sights on J&J spinout Kenvue: WSJ

Activist investor Starboard Value, which picked up a $1 billion stake in Pfizer earlier this month, now reportedly has ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results